3Sen M, Wankowski DM, Garlie NK, et al. Use of anti-CD3 x antiHER2/neu bispecific antibody for redirecting cytotoxicity of activated T cells toward HER2/neu + tumors. Hematother Stem Cell Res,2001, 10: 247-260.
2Ishida T,Tmai K.The expression technology of chimeric and humanized antibodies[J].Nippon Rinsho,2002,60(3):439-444.
3Lum LG,Sen M.Activated T-cell and bispecific antibody immunotherapy for hish-risk breast cancer.Bench to bedside[J].Acta Hacmatol,2001,105(3):130-136.
4Gelderman KA,Blok VT,Fleuren GJ,et al.The inhibitory effect of CD46,CD55,and CD59 on complement activation after immunotherapeutic treatment of cervical carcinoma cells with monoclonal antibodies or bispecific monoclonal antibodies[J].Lab Invest,2002,82(4):483-493.
5Jimenez X,Lu D,Brennan L,et al.A recombinant fully human bispecific antibody neutralizes the biological activities mediated by both vascular endothelial growth factor receptors 2 and 3[J].Mol Cancer Ther,2005,4(3):427-434.
6Hurwita HI,Fehrenbacher L,Hainsworth JD,et al.Bevacizumab in combination with fluorouracil and leucovorin:an active regimen for firstline metastatic colorectal cancer[J].J Clin Oncol,2005,23(15):3502-3508.
7Cui H,Chang XH,Liu B,et al.The anti-tumor immune responses induced by a fusion protein of ovarian carcinoma anti-idiotypic antibody 6B11ScFv and murine GM-CSF in BALB/c mice[J].Int J Gynecol Cancer,2004,14(2):234-241.
8Hansen MH,Stenstad B,Sioud M.Identification of immumogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinloma tumour[J].Int J Oncol,2001,19(6):1303-1309.
10Wormstone IM,Tamiva S,Anderson I,et al.TGF-beta-2 induced matrix modifieation and cell transdifferentiation in the human lens capsular bag[J].Invest Ophthalmol Vis Sci,2002,43(7):2301-2308.
